Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysisGlenn Jun Kit Ho, Faith Xin Ning Tan, N Apoorva Sasikumar, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2022
UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 StudiesDarren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, et al.
Transplantation Direct|June 24, 2024
Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASHJia Hong Koh, Douglas Chee, Cheng Han Ng, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The American Journal of Gastroenterology|October 3, 2022
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 ParticipantsPhoebe Wen Lin Tay, Cheng Han Ng, Snow Yunni Lin, et al.
Hepatology Communications|March 2, 2022
Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studiesRosyli F Reveron-Thornton, Margaret L P Teng, Eunice Yewon Lee, et al.
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation studyYu Jun Wong, Guan Sen Kew, Poh Seng Tan, et al.
Biomedicines|October 27, 2022
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency AblationBenjamin Wei Rong Tay, Daniel Q Huang, Muthiah Mark, et al.
Pageof 23